Synthesis of celecoxib and structural analogs- a review

Current Organic Chemistry

Volumn 16, Issue 11, 2012, Pages 1390-1407

  Dadiboyena, Sureshbabu ^a   Hamme II, Ashton T ^b  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^b Jackson State University   (United States)

Author keywords

And Condensations; Celebrex ; Celecoxib; Couplings; COX; Cycloadditions; Heterocycles; Pyrazoles

Indexed keywords

DRUG INTERACTIONS; ORGANIC COMPOUNDS; SULFUR COMPOUNDS;

AND CONDENSATION; CELEBREX®; CELECOXIB; CYCLOADDITIONS; CYCLOOXYGENASE ENZYME; CYCLOOXYGENASES; HETEROCYCLES; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; PYRAZOLES; STRUCTURAL ANALOGUE;

DISEASES;

EID: 84861758785     PISSN: 13852728     EISSN: None     Source Type: Journal    
DOI: 10.2174/138527212800672664     Document Type: Review

References (108)

1. Bhat, G. A.; Montero, J.-L. G.; Panzica, R. P.; Wotring, L. L.; Townsend, L. B. Pyrazolo-pyrimidine nucleosides. 12. Synthesis and biological activity of certain pyrazolo[3,4-d]pyrimidine nucleosides related to adenosine. J. Med. Chem. 1981, 24, 1165-1172.
2. Petrie, C. R. III; Cottam, H. B.; McKernan, P. A.; Robins, R. K.; Revankar, G. R. Synthesis and biological activity of 6-azacadeguomycin and certain 3,4,6-trisubstituted pyrazolo[3,4-d]pyrimidine ribonucleosides. J. Med. Chem. 1985, 28, 1010-1016.
3. Penning, T. D.; Talley, J. J.; Bertenshaw, S. R.; Carter, J. S.; Collins, P. W.; Docter, S.; Graneto, M. J.; Lee, L. F.; Malecha, J. W.; Miyashiro, J. M.; Rogers, R. S.; Rogier, D. J.; Yu, S. S.; Anderson, G. D.; Burton, E. G.; Cogburn, J. N.; Gregory, S. A.; Koboldt, C. M.; Perkins, W. E.; Seibert, K.; Veenhuizen, A. W.; Zhang, Y. Y.; Isakson, P. C. Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors: Identification of 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib). J. Med. Chem. 1997, 40, 1347-1365.
4. Elguero, J. In Comprehensive Heterocyclic Chemistry II; Katrizky, A. R.; Rees, C. W.; Scriven, E. F. V.; Pergamon: Oxford, 1996; Vol. 3, p 1-8.
5. Patel, J. B.; Malick, J. B.; Salama, A. I.; Goldberg, M. E. Pharmacology of pyrazolopyridines. Pharmacol. Biochem. And Behavior 1985, 23, 675-680.
6. Vicentini, C. B.; Mares, D.; Tartari, A.; Manfrini, M.; Forlani, G. Synthesis of Pyrazole Derivatives and Their Evaluation as Photosynthetic Electron Transport Inhibitors. J. Agri. Food Chem. 2004, 52, 1898-1906.
7. Dadiboyena, S. Recent advances in the synthesis of raloxifene: A selective Estrogen receptor modulator. Eur. J. Med. Chem. http://dx.doi.org/10.1016/j.ejmech.2012.02.021.
8. Reitz, D. B.; Isakson, P. C. Cyclooxygenase-2 Inhibitors. Curr. Pharm. Des. 1995, 1, 211-220.
9. Dadiboyena, S.; Nefzi, A. Synthesis of functionalized tetrasubstituted pyrazolyl heterocycles. Eur. J. Med. Chem. 2011, 46, 5258-5275.
10. Chavatte, P.; You, S.; Marot, C.; Baurin, N.; Lesieur, D. Three-Dimensional Quantitative Structure→Activity Relationships of Cyclo-oxygenase-2 (COX-2) Inhibitors: A Comparative Molecular Field Analysis. J. Med. Chem. 2001, 44, 3223-3230.
11. Salimi, M.; Ghahremani, M. H.; Naderi, N.; Amini, M.; Salimi, E.; Amanlou, M.; Abdi, K.; Salehi, R.; Shafiee, A. Design, synthesis and pharmacological evaluation of 4-[2-alkylthio-5(4)-(4-substitutedphenyl)imidazole-4(5)yl]benzenesulfonamides as selective COX-2 inhibitors. Acta Pharmacol Sin 2007, 28, 1254.
12. Erdélyi, P.; Fodor, T.; Varga, A. K.; Czugler, M.; Gere, A.; Fischer, J. Chemical and biological investigation of N-hydroxy-valdecoxib: An active metabolite of valdecoxib. Bioorg. Med. Chem. 2008, 16, 5322-5330.
13. Bekhit, A. A.; Ashour, H. M. A.; Abdel Ghany, Y. S.; Bekhit, A. E.-D. A.; Baraka, A. Synthesis and biological evaluation of some thiazolyl and thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents. Eur. J. Med. Chem. 2008, 43, 456-463.
14. Chowdhury, M. A.; Abdellatif, K. R. A.; Dong, Y.; Knaus, E. E. Synthesis of new 4-[2-(4-methyl(amino)sulfonylphenyl)-5-trifluoromethyl-2H-pyrazol-3-yl]-1,2,3,6-tetrahydro-pyridines: A search for novel nitric oxide donor antiinflammatory agents Bioorg. Med. Chem. 2008, 16, 8882-8888.
15. Schroeder, C. P.; Kadara, H.; Lotan, D.; Woo, J. K.; Lee, H.-Y.; Hong, W. K.; Lotan, R. Involvement of Mitochondrial and Akt Signaling Pathways in Augmented Apoptosis Induced by a Combination of Low Doses of Celecoxib and N-(4-Hydroxyphenyl) Retinamide in Premalignant Human Bronchial Epithelial Cells. Cancer Res. 2006, 16, 9762-9770.
16. Herschman, H. R. Prostaglandin-2 synthase. Biochim. Biophys. Acta 1996, 1299, 125-40.
17. Turini, M. E.; DuBios, R. N. Cyclooxygenase-2: a therapeutic target. Annu. Rev. Med. 2002, 53, 35-57.
18. Simmons, D. L.; Botting, R. M.; Hla, T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol. Rev. 2004, 56, 387-437.
19. Song, Y.; Connor, D. T.; Doubleday, R.; Sorenson, R. J.; Sercel, A. D.; Unangst, P. C.; Roth, B. D.; Gilbertson, R. B.; Chan, K.; Schrier, D. J.; Guglietta, A.; Bornemeier, D. A.; Dyer, R. D. Synthesis, Structure→Activity Relationships, and in Vivo Evaluations of Substituted Di-tert-butylphenols as a Novel Class of Potent, Selective, and Orally Active Cyclooxygenase-2 Inhibitors. 1. Thiazolone and Oxazolone Series. J. Med. Chem. 1999, 42, 1151-1160.
20. Chandrasekharan, N. V.; Dai, H.; Roos, K. L.; Evanson, N. K.; Tomsik, J.; Elton, T. S.; Simmons, D. L. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 13926-13931.
21. Dadiboyena, S.; Nefzi, A. Recent methodologies toward the synthesis of valdecoxib: A potential 3,4-diarylisoxazolyl COX-II inhibitor. Eur. J. Med. Chem. 2010, 45, 4697-4707.
22. Romeiro, N. C.; Leite, R. D. F.; Lima, L. M.; Cardozo, S. V. S.; de Miranda, A. L. P.; Fraga, C. A. M.; Barreiro, E. J. Synthesis, pharmacological evaluation and docking studies of new sulindac analogues. Eur. J. Med. Chem. 2009, 44, 1959-1971.
23. Xie, W.; Chipman, J. G.; Robertson, D. L.; Erikson, R. L.; Simmons, D. L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 2692-2696.
24. Kujubu, D. A.; Fletcher, B. S.; Varnum, B. C.; Lim, R. W.; Herschman, H. R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 1991, 266, 12866-12872.
25. O'Banion, M. K.; Sadowski, H. B.; Winn, V.; Young, D. A. A. A serum-and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenaserelated protein. J. Biol. Chem. 1991, 266, 23261-7.
26. Ramana Reddy, M. V.; Billa, V. K.; Pallela, V. R.; Mallireddigari, M. R.; Boominathan, R.; Gabriel, J. L.; Premkumar Reddy, E. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors. Bioorg. Med. Chem. 2008, 16, 3907-3916.
27. Talley, J. J.; Bertenshaw, S. R.; Brown, D. L.; Carter, J. S.; Graneto, M. J.; Kellogg, M. S.; Koboldt, C. M.; Yuan, J.; Zhang, Y. Y.; Seibert, K. N-[(5-Methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, Sodium Salt, Parecoxib Sodium: A Potent and Selective Inhibitor of COX-2 for Parenteral Administration. J. Med. Chem. 2000, 43, 1661-1663.
28. Talley, J. J. Selective Inhibitors of COX-2. In Progress in Medicinal Chemistry 36; King, F. D., Oxford, A., Eds.; Elsevier: Amsterdam, 1999; pp 201-234.
29. Toyokuni, T.; Dileep Kumar, J. S.; Walsh, J. C.; Shapiro, A.; Talley, J. J.; Phelps, M. E.; Herschman, H. R.; Barrio, J. R.; Satyamurthy, J. R. Synthesis of 4-(5-[18F]fluoromethyl-3-phenylisoxazol-4-yl)benzenesulfonamide, a new [18F]fluorinated analogue of valdecoxib, as a potential radiotracer for imaging cyclooxygenase-2 with positron emission tomography. Bioorg. Med. Chem. Lett. 2005, 15, 4699-4702.
30. Prabhakaran, J.; Majo, V. J.; Simpson, N. R.; Van Heetum, R. L.; Mann, J. J.; Dileep-Kumar, J. S. Synthesis of [11C]celecoxib: a potential PET probe for imaging COX-2 expression. J. Labelled Compd. Radiopharm. 2005, 48, 887-895.
31. Kalgutkar, A. S. Selective Cyclooxygenase-2 Inhibitors as Non-Ulcerogenic Antiinflammatory Agents. Exp. Opin. Ther. Patents 1999, 8, 831-849.
32. Vane, J. R.; Bakhle, Y. S.; Botting, R. M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 1998, 38, 97-120.
33. Habeeb, A. G.; Rao, P. N. P.; Knaus, E. E. Design and Synthesis of Celecoxib and Rofecoxib Analogues as Selective Cyclooxygenase-2 (COX-2) Inhibitors: Replacement of Sulfonamide and Methylsulfonyl Pharmacophores by an Azido Bioisostere. J. Med. Chem. 2001, 44, 3039-3042.
34. Kurumbail, R. G.; Stevens, A. M.; Gierse, J. K.; McDonald, J. J.; Stegeman, R. A.; Pak, J. Y.; Gildehaus, D.; Miyashiro, J. M.; Penning, T. D.; Seibert, K.; Isakson, P. C.; Stallings, W. C. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 1996, 384, 644-648.
35. Walker, M. C.; Kurumbail, R. G.; Kiefer, J. R.; Moreland, K. T.; Koboldt, C. M.; Isakson, P. C.; Seibert, K.; Gierse, J. K. A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors. Biochem. J. 2001, 357, 709-718.
36. Huisgen, R. 1,3-Dipolar Cycloadditions. Past and Future. Angew. Chem. Int. Ed. Engl. 1963, 2, 565-598.
37. Huisgen, R. Kinetics and Mechanism of 1,3-Dipolar Cycloadditions. Angew. Chem. Int. Ed. Engl. 1963, 2, 633-645.
38. Dadiboyena, S.; Hamme, A. T. II One pot spiropyrazoline synthesis via intramolecular cyclization/methylation. Tetrahedron Lett. 2011, 52, 2536-2539.
39. Dadiboyena, S.; Valente, E. J.; Hamme, A. T. II Synthesis of novel pyrazoles via [2+3]-dipolar cycloaddition using alkyne surrogates. Tetrahedron Lett. 2010, 51, 1341-1343.
40. Dadiboyena, S. Xu, J.; Hamme, A. T. II Isoxazoles from 1,1-disubstituted bromoalkenes. Tetrahedron Lett. 2007, 49, 1295-1298.
41. Dadiboyena, S.; Nefzi, A. Solid phase synthesis of isoxazole and isoxazoline-carboxamides via [2+3]-dipolar cycloaddition using resin-bound alkynes or alkenes. Tetrahedron Lett. 2012, 53, 2096-2099.
42. Dadiboyena, S.; Valente, E. J.; Hamme, A. T. II A novel synthesis of 1,3,5-trisubstituted pyrazoles through a spiro-pyrazoline intermediate via a tandem 1,3-dipolar cycloaddition/elimination. Tetrahedron Lett. 2009, 50, 291-294.
43. Abdellatif, K. R. A.; Chowdhury, M. A.; Dong, Y.; Chen, Q.-H.; Knaus, E. E. A new non-azole inhibitor of ABA 8'-hydroxylase: Effect of the hydroxyl group substituted for geminal methyl groups in the six-membered ring. Bioorg. Med. Chem. 2008, 16, 3302-3305.
44. Chowdhury, M. A.; Dong, Y.; Chen, Q.-H.; Abdellatif, K. R. A.; Knaus, E. E. Synthesis and cyclooxygenase inhibitory activities of linear 1-(methanesulfonylphenyl or benzenesulfonamido)-2-(pyridyl)acetylene regioisomers. Bioorg. Med. Chem. 2008, 16, 1948-1956.
45. Zarghi, A.; Kakhgi, S.; Hadipoor, A.; Daraee, B.; Dadrass, O. G.; Hedayati, M. Design and synthesis of 1,3-diarylurea derivatives as selective cyclooxygenase (COX-2) inhibitors. Bioorg. Med. Chem. Lett. 2008, 18, 1336-1339.
46. Gadad, A.; Palkar, M. B.; Anand, K.; Noolvi, M. N.; Boreddy, T. S.; Wagwade, J. Synthesis and biological evaluation of 2-trifluoromethyl/sulfonamido-5,6-diaryl substituted imidazo[2,1-b]-1,3,4-thiadiazoles: A novel class of cyclooxygenase-2 inhibitors. Bioorg. Med. Chem. 2008, 16, 276-283.
47. Seo, H. J.; Kim, M. J.; Lee, S. H.; Lee, S.-H.; Jung, M. E.; Kim, M.-S.; Ahn, K.; Kim, J.; Lee, J. Synthesis and structure-activity relationship of 1,2,4-triazole-containing diarylpyrazolyl carboxamide as CB1 cannabinoid receptor-ligand. Bioorg. Med. Chem. 2010, 18, 1149-1162.
48. Oh, L. Synthesis of celecoxib via 1,3-dipolar cycloaddition. Tetrahedron Lett. 2006, 47, 7943-7946.
49. Miyaura, N.; Yamada, K.; Suzuki, A. A new stereospecific cross-coupling by the palladium-catalyzed reaction of 1-alkenylboranes with 1-alkenyl or 1-alkynyl halides. Tetrahedron Lett. 1979, 20, 3437-3440.
50. Miyaura, N.; Suzuki, A. Stereoselective synthesis of arylated (E)-alkenes by the reaction of alk-1-enylboranes with aryl halides in the presence of palladium catalyst. J. Chem. Soc., Chem. Commun. 1979, 866-867.
51. Miyaura, N. Organoboron Compounds. Top. Curr. Chem. 2002, 219, 11-59.
52. Kotha, S.; Lahiri, K.; Kashinath, D. Recent applications of the Suzuki-Miyaura cross-coupling reaction in organic synthesis. Tetrahedron 2002, 58, 9633-9695.
53. Miyaura, N.; Suzuki, A. Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds. Chem. Rev. 1995, 95, 2457-2483.
54. Negishi, E.; Okukado, N.; Lovich, S. F.; Luo, F. T. A method for the preparation of terminal and internal conjugated diynes via palladium-catalyzed cross-coupling. J. Org. Chem. 1984, 49, 2629-2632.
55. Negishi, E.-I.; Anastasia, L. Palladium-Catalyzed Alkynylation. Chem. Rev. 2003, 103, 1979-2018.
56. Farina, V.; Krishanamurthy, V.; Scott, W. J. The Stille Reaction; Wiley: New York, 1998, 1-676.
57. Suzuki, A. Recent advances in the cross-coupling reactions of organoboron derivatives with organic electrophiles, 1995-1998. J. Organomet. Chem. 1999, 576, 147-168.
58. De Frutos, O.; Atienza, C.; Echavarren, A. M. Synthesis of Benzo[b]phenanthridines and Related Naturally Occurring 2-Aryl-1,4-naphthoquinones by Palladium-and Copper-Catalyzed Coupling of Organostannanes with Bromoquinones. Eur. J. Org. Chem. 2001, 163-171.
59. Xu, J.; Burton, D. J. Stereospecific preparation of (Z)-'-fluorostilbenes via a kinetically controlled palladium-catalyzed cross-coupling reaction of high E/Z ratio 1-bromo-1-fluorostyrenes and aryl stannanes. Tetrahedron Lett. 2002, 43, 2877-2879.
60. Organ, M. G.; Mayer, S. Synthesis of 4-(5-Iodo-3-Methylpyrazolyl) Phenylsulfonamide and Its Elaboration To a COX II Inhibitor Library by Solution-Phase Suzuki Coupling Using Pd/C as a Solid-Supported Catalyst. J. Comb. Chem. 2003, 5, 118-124.
61. Wang, X.-J.; Tan, J.; Grozinger, K. Cross-coupling of 1-aryl-5-bromopyrazoles: regioselective synthesis of 3,5-disubstituted 1-arylpyrazoles. Tetrahedron Lett. 2000, 41, 4713-4716.
62. Sakurai, H.; Tsukuda, T.; Hirao, T. Pd/C as a Reusable Catalyst for the Coupling Reaction of Halophenols and Arylboronic Acids in Aqueous Media. J. Org. Chem. 2002, 67, 2721-2722.
63. Mark, G.; Villiger, A.; Buchecker, R. Aryl couplings with heterogeneous palladium catalysts. Tetrahedron Lett. 1994, 35, 3277-3280.
64. Ennis, D. S.; McManus, J.; Wood-Kaczmar, W.; Richardson, J.; Smith, G.; Carstairs, A. Multikilogram-Scale Synthesis of a Biphenyl Carboxylic Acid Derivative Using a Pd/C-Mediated Suzuki Coupling Approach. Org. Process Res. Dev. 1999, 3, 248-252.
65. Hernandez, S.; SanMartin, R.; Tellitu, I.; Dominguez, E. Toward Safer Methodologies for the Synthesis of Polyheterocyclic Systems: Intramolecular Arylation of Arenes under Mizoroki→Heck Reaction Conditions. Org. Lett. 2003, 5, 1095-1098.
66. Hernandez, S.; Moreno, I.; SanMartin, R.; Gomez, G.; Herrero, M. T.; Dominguez, E. Toward Safer Processes for C→C Biaryl Bond Construction: Catalytic Direct C→H Arylation and Tin-Free Radical Coupling in the Synthesis of Pyrazolophenanthridines. J. Org. Chem. 2010, 75, 434-441.
67. Olivera, R.; SanMartin, R.; Domi{dotless}nguez, E. A Combination of Tandem Amine-Exchange/Heterocyclization and Biaryl Coupling Reactions for the Straightforward Preparation of Phenanthro[9,10-d]pyrazoles. J. Org. Chem. 2000, 65, 7010-7019.
68. Olivera, R.; SanMartin, R.; Churruca, F.; Domi{dotless}nguez, E. Revisiting the Ullmann→Ether Reaction: A Concise and Amenable Synthesis of Novel Dibenzoxepino[4,5-d]pyrazoles by Intramolecular Etheration of 4,5-(o, o'-Halohydroxy)arylpyrazoles. J. Org. Chem. 2002, 67, 7215-7225.
69. Olivera, R.; SanMartin, R.; Tellitu, I.; Domi{dotless}nguez, E. The amine exchange/biaryl coupling sequence: a direct entry to the phenanthro[9,10-d]heterocyclic framework. Tetrahedron 2002, 58, 3021-3037.
70. Uddin, M. J.; Praveen Rao, P. N.; Knaus, E. E. Design and synthesis of novel celecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of the sulfona-mide pharmacophore by a sulfonylazide bioisostere. Bioorg. Med. Chem. 2003, 11, 5273-5280.
71. Raushel, J.; Pitram, S. M.; Fokin, V. V. Efficient Synthesis of Sulfonyl Azides from Sulfonamides. Org. Lett. 2008, 10, 3385-3388.
72. Soliman, R. Preparation and antidiabetic activity of some sulfonylurea derivatives of 3,5-disubstituted pyrazoles. J. Med. Chem. 1979, 22, 321-325.
73. Hashimoto, H.; Imamura, K.; Haruta, J.-I.; Wakitani, K. 4-(4-Cycloalkyl/aryl-oxazol-5-yl)benzenesulfonamides as Selective Cyclooxygenase-2 Inhibitors: Enhancement of the Selectivity by Introduction of a Fluorine Atom and Identification of a Potent, Highly Selective, and Orally Active COX-2 Inhibitor JTE-522. J. Med. Chem. 2002, 45, 1511-1517.
74. Chowdhury, M. A.; Abdellatif, K. R. A.; Dong, Y.; Das, D.; Suresh, M. R.; Knaus, E. E. Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: Biological evaluation as dual inhibitors of cyclooxygenases and 5-lipox-ygenase with anti-inflammatory activity. Bioorg. Med. Chem. Lett. 2008, 18, 6138-6141.
75. Chowdhury, M. A.; Abdellatif, K. R. A.; Dong, Y.; Das, D.; Suresh, M. R.; Knaus, E. E. Synthesis of Celecoxib Analogues Possessing a NDifluoromethyl-1,2-dihydropyrid-2-one 5-Lipoxygenase Pharmacophore: Biological Evaluation as Dual Inhibitors of Cyclo-oxygenases and 5-Lipoxygenase with Anti-Inflammatory Activity. J. Med. Chem. 2009, 52, 1525-1529.
76. Abdellatif, K. R. A.; Chowdhury, M. A.; Dong, Y.; Das, D.; Velazquez, C.; Suresh, M. R.; Knaus, E. E. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-carboxymethylphenyl)-1-(4-methanesulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its aminosulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies. Bioorg. Med. Chem. 2009, 17, 5182-5188.
77. Abdellatif, K. R. A.; Chowdhury, M. A.; Dong, Y.; Velazquez, C.; Das, D.; Suresh, M. R.; Knaus, E. E. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies. Bioorg. Med. Chem. 2008, 16, 9694-9698.
78. Velázquez, C.; Chen, Q.-H.; Citro, M. L.; Keefer, L. K.; Knaus, E. E. Second-Generation Aspirin and Indomethacin Prodrugs Possessing an O2-(Acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate Nitric Oxide Donor Moiety: Design, Synthesis, Biological Evaluation, and Nitric Oxide Release Studies. J. Med. Chem. 2008, 51, 1954-1961.
79. Abdellatif, K. R. A.; Chowdhury, M. A.; Dong, Y.; Knaus, E. E. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 1-(4-methanesulfonylphenyl)-5-aryl-1H-pyrazol-3-carboxylic acids: Synthesis, nitric oxide release studies and anti-inflammatory activities. Bioorg. Med. Chem. 2008, 16, 6528-6534.
80. Huang, H.-C.; Li, J. J.; Garland, D. J.; Chamberlain, T. S.; Reinhard, E. J.; Manning, R. E.; Seibert, K.; Koboldt, C. M.; Gregory, S. A.; Anderson, G. D.; Veenhuizen, A. W.; Zhang, Y.; Perkins, W. E.; Burton, E. G.; Cogburn, J. N.; Isakson, P. C.; Reitz, D. B. Diarylspiro[2.4]heptenes as Orally Active, Highly Selective Cyclooxygenase-2 Inhi-bitors: Synthesis and Structure →Activity Relationships. J. Med. Chem. 1996, 39, 253-266.
81. Ando, M.; Wada, T.; Sato, N. Facile One-Pot Synthesis of NDifluoromethyl-2-pyridone Derivatives. Org. Lett. 2006, 8, 3805-3808.
82. Levine, R.; Sneed, J. K. The Synthesis of New κ-Diketones. J. Am. Chem. Soc. 1951, 73, 4478.
83. Nielsen, A. T.; Moore, D. W.; Mazur, J. H.; Berry, K. H. Thermal Cleavage of 1,1'-Diacetyl-1,1',4,4'-tetrahydro-4,4'-bipyridine. J. Org. Chem. 1964, 29, 2898-2903.
84. Waters, J. A.; Spivak, C. E.; Hermsmeier, M.; Yadav, J. S.; Liang, R. F.; Gund, T. M. Synthesis, pharmacology, and molecular modeling studies of semirigid, nicotinic agonists. J. Med. Chem. 1988, 31, 545-554.
85. Szabo, G.; Fischer, J.; Kis-Varga, A.; Gyires, K. New Celecoxib Derivatives as Anti-Inflammatory Agents. J. Med. Chem. 2008, 51, 142-147.
86. Navidpour, L.; Amini, M.; Shafaroodi, H.; Abdi, K.; Ghahremani, M. H.; Dehpour, A. R.; Shafiee, A. Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors. Bioorg. Med. Chem. Lett. 2006, 16, 4483-4487.
87. Shie, J.-J.; Fang, J.-M. Direct Conversion of Aldehydes to Amides, Tetrazoles, and Triazines in Aqueous Media by One-Pot Tandem Reactions. J. Org. Chem. 2003, 68, 1158-1160.
88. Menozzi, G.; Merello, L.; Fossa, P.; Mosti, L.; Piana, A.; Mattioli, F. 4-substituted 1,5-diarylpyrazole, analogues of celecoxib: synthesis and preliminary evaluation of biological properties. Farmaco 2003, 58, 795-808.
89. Ahlstrom, M. M.; Ridderstrom, M.; Zamora, I.; Luthman, K. CYP2C9 Structure →Metabolism Relationships: Optimizing the Metabolic Stability of COX-2 Inhibitors. J. Med. Chem. 2007, 50, 4444-4452.
90. Li, S. X.; Deng, X. D.; Jiang, F. L.; Zhao, Y. J.; Xiao, W. S.; Kuang, X. Z.; Sun, X. M. Design and Synthesis of Novel Diaryl Heterocyclic Derivatives as Selective Cyclooxygenase-2. Lett. Drug Design & Discovery 2008, 5, 127-133.
91. Fang, Y.; Leysen, D.; Ottenheijm, H. C. A Facile Synthesis of N-Substituted Pyrroles. Synth. Commun. 1995, 25, 1857-1861.
92. Pal, M.; Madan, M.; Srinivas, P.; Pattabiraman, V. R.; Srinivas, K.; Akhila, V.; Ramesh, M.; Mamidi, N.V.S.R.; Seshagiri, R.C.; Alpeshkumar, M.; Gopalakrishnan, B.; Rao, Y. K. Synthesis and Cyclooxygenase-2 Inhibiting Property of 1,5-Diarylpyrazoles with Substituted Benzenesulfonamide Moiety as Pharmacophore: Preparation of Sodium Salt for Injectable Formulation. J. Med. Chem. 2003, 46, 3975-3984, and references cited therein.
93. Pal, M.; Veeramaneni, V. R.; Kumar, S.; Vangoori, A.; Mullangi, R.; Misra, P.; Rajjak, S. A.; Lohray, V. B.; Casturi, S. R.; Yeleswarapu, K. R. Synthesis and Cyclooxygenase-2 (COX-2) Inhibiting Properties of 1,5-Diarylpyrazoles Possessing N-Substitution on the Sulfonamide (-SO2NH2) Moiety. Lett. Drug Design & Discovery 2005, 2, 329-340, and references cited therein.
94. Abdel Aal, E. H.; El-Sabbagh, O. I.; Youssif, S.; El-Nabtity, S. M. Synthesis and Some Pharmacological Studies of New Benzenesulfonamide Derivatives. Monatsch. Chem. 2002, 133, 255-266.
95. Singh, S. K.; Reddy, P. G.; Rao, K. S.; Lohray, B. B.; Misra, P.; Rajjak, S. A.; Rao, Y. K.; Venkateswarlu, A. Polar substitutions in the benzenesulfonamide ring of celecoxib afford a potent 1,5-diarylpyrazole class of COX-2 inhibitors. Bioorg. Med. Chem. Lett. 2004, 14, 499-504.
96. Popic, V. V.; Korneev, S. M.; Nikolaev, V. A.; Korobitsyna, I. K. An Improved Synthesis of 2-Diazo-1,3-diketones. Synthesis 1991, 195-198.
97. Anselme, J. P. Cleavage of κ-ketonic esters by the action of metal iodides. II. Action of hydrate sodium and calcium iodides on acetoacetic ester and its '-methylated derivatives. J. Org. Chem. 1967, 32, 3716-3718.
98. de Vries, E. F.; Doorduin, J.; Dierckx, R. A.; van Waarde, A. Evaluation of [11C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation. Nucl. Med. Biol. 2008, 35, 35-42.
99. Kuge, Y.; Obokata, H.; Kimura, H.; Katada, Y.; Temma, T.; Sugimoto, Y.; Aita, K.; Seki, K.; Tamaki, N.; Saji, H. Synthesis and evaluation of a radioiodinated lumiracoxib derivative for the imaging of cyclooxygenase-2 expression. Nucl. Med. Biol. 2009, 36, 869-876.
100. Kuge, Y.; Katada, Y.; Shimonaka, S.; Temma, T.; Kimura, H.; Kiyono, Y.; Yokota, C.; Minematsu, K.; Seki, K.; Tamaki, N.; Ohkura, K.; Saji, H. Synthesis and evaluation of radioiodinated cyclooxygenase-2 inhibitors as potential SPECT tracers for cyclooxygenase-2 expression. Nucl. Med. Biol. 2006, 33, 21-27.
101. Prabhakaran, J.; Majo, V. J.; Simpson, N. R.; Van Heetum, R. L.; Mann, J. J.; Dileep-Kumar, J. S. Synthesis of [11C]celecoxib: a potential PET probe for imaging COX-2 expression. J. Labelled Compd. Radiopharm. 2005, 48, 887-895.
102. Prabhakaran, J.; Underwood, M. D.; Parsey, R. V.; Arango, V.; Majo, V. J.; Simpson, N. R.; Heertum, R. V.; Mann, J. J.; Dileep-Kumar, J. S. Synthesis and in vivo evaluation of [18F]-4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide as a PET imaging probe for COX-2 expression. Bioorg. Med. Chem. 2007, 15, 1802-1807.
103. Uddin, Md.; Crews, B. C.; Ghebreselasie, K.; Huda, I.; Kingsley, P. J.; Ansari, M. S.; Tantawy, M. N.; Reese, J.; Marnett, L. J. Fluorinated COX-2 Inhibitors as Agents in PET Imaging of Inflammation and Cancer. Cancer Prev Res. 2011, 4, 1536-1545.
104. Gao, M.; Wang, M.; Miller, K. D.; Hutchins, G. D.; Zheng, Q.-H. Synthesis of carbon-11 labeled celecoxib derivatives as new candidate PET radioligands for imaging of inflammation. Applied Radiation and Isotopes 2009, 67, 2019-2024.
105. Gao, M.; Wang, M.; Miller, K. D.; Zheng, Q.-H. Synthesis and preliminary in vitro biological evaluation of new carbon-11-labeled celecoxib derivatives as candidate PET tracers for imaging of COX-2 expression in cancer. Eur. J. Med. Chem. 2011, 46, 4760-4767.
106. El-Azony, K. M. Preparation of 125I-celecoxib with high purity as a possible tumor agent. J. Radioanal. Nucl. Chem. 2010, 285, 315-320.
107. Uddin, M. J.; Crews, B. C.; Ghebreselasie, K.; Tantawy, M. N.; Marnett, L. J. [123I]-Celecoxin analogues as SPECT tracers of cyclooxygenase-II in inflammation. ACS Med. Chem. Lett. 2011, 2, 160-164.
108. Uddin, M. J.; Crews, B. C.; Blobaum, A. L.; Kingslay, P. J.; Ghebreselasie, K.; Saleh, S. S.; Clanton, J. A.; Baldwin, R. M.; Marnett, L. J. Synthesis and evaluation of [123I]-indomethacin derivatives as COX-II targeted imaging agents. J. Labelled Compd. Radiopharm. 2010, 52, 387-393.